Pages Menu
ISSN (Online): 2348-3962,
ISSN (Print): 2394-5583

International Journal Of Pharmacognosy

An International Journal published monthly
An Official Publication of Society of Pharmaceutical Sciences and Research

Categories Menu

Volume 6 (2019) - Issue 12, December

Review Articles

 
Title
Views
PDF
Cited
1.

A REVIEW ON EFFECT OF SEASONAL VARIATION ON PHYTOCHEMICALS OF MEDICINAL PLANTS

Herbs are used as a source of medicine in Ayurveda and also in some traditional systems of medicine as having lesser side effects and cost when compared with synthetic drugs. Plants live on a planet with days and seasons, and that affects their phytoconstituents. The availability of active principles in medicinal plants changes by seasonal fluctuations, so their dose pattern for therapeutic effica...

G. Palshikar *, S. Ambavade and P. Shanmugapandiyan

JSPM’s Jayawantrao Sawant College of Pharmacy, Hadapsar, Pune, Maharashtra, India.

DOI: 10.13040/IJPSR.0975-8232.IJP.6(12).374-81

374-381

1195

0

2.

MALARIA AND ANTIMALARIAL ACTIVITY OF MEDICINAL PLANTS: A REVIEW

Natural compounds have already contributed to the discovery of new anti-malarial drugs. Atovaquone, artemisinin and its semi-synthetic derivatives as well as clindamycin, erythromycin, azithromycin, chlortetracycline, tetracycline, oxytetracycline and doxycycline, are noteworthy examples of the varied contribution of natural products for the development of effective anti-malarial drugs, particular...

S. S. Raut

K. K. Wagh College of Pharmacy, Amrutdham, Nashik, Maharashtra, India.

DOI: 10.13040/IJPSR.0975-8232.IJP.6(12).382-89

382-389

1078

0

Research Articles

 
Title
Views
PDF
Cited
3.

POLYPHENOLIC PROFILE ANTIOXIDANT POTENTIAL AND ANTIMICROBIAL ACTIVITY OF CHRYSACTINIA MEXICANA A. GRAY (HIERBA DE SAN NICOLAS)

The objective of this study was the extraction, recuperation, identification and bioactivity evaluation of the main bioactive compounds present in Chrysactinia mexicana A. Gray, polyphenolic compounds from aerial parts of Chrysactinia mexicana A. Gray were purified using a liquid chromatography column with ambulate XAD-16, first elution was made with distilled water, then ethanol was used to recov...

E. Gomez-Macias, M. A. Mellado-Bosque, J. A. Ascacio-Valdes, V. E. Aguirre-Arzola, G. C. G. Martinez-Avila, C. N Aguilar and Aaguilera-Carbo *

Animal Nutrition Department, Universidad Autonoma Agraria “Antonio Narro”, Col. Buena Vista, Calzada Antonio Narro No. 1923, Saltillo, Coahuila, Mexico.

DOI: 10.13040/IJPSR.0975-8232.IJP.6(12).390-96

390-396

1091

364

4.

CHARACTERIZATION OF PHYTOCHEMICAL AND ANTIOXIDANT PROPERTIES OF CITRUS AURANTIFOLIA (KAGOJI LEBU) AVAILABLE IN BANGLADESH AND ITS PROTECTIVE EFFECTS AGAINST EXPERIMENTALLY INDUCED MYOCARDIAL INFARCTION IN RATS

Plants and fruits have medicinal purposes, and they are being used long before the prehistoric period. Among the different varieties of citrus fruits, Citrus aurantifolia (Kagoji labu) is widespread in tropical and subtropical regions around the World. It is one of the major citrus fruits and widely consumed, but there is limited evidence about its health-promoting properties. In the present study...

A. Kabir, R. Karim, M. Y. Ali, M. I. Khalil and M. I. Hossain *

Laboratory of Preventive and Integrative Biomedicine, Department of Biochemistry and Molecular Biology, Jahangir Nagar University, Savar, Dhaka, Bangladesh.

DOI: 10.13040/IJPSR.0975-8232.IJP.6(12).397-06

397-406

1400

404

5.

EFFICACY OF TOPICAL NEPAFENAC IN THE TREATMENT OF DIABETIC MACULAR EDEMA- A CLINICAL STUDY

To analyze the efficacy of topical nepafenac, 0.1% eye drops in the treatment of diabetic macular edema (DME). Method: a prospective interventional study in 14 eyes having center involving DME were taken into consideration. They were administered topical nepafenac eye drops 0.1% thrice daily for 6 months. Their vision and foveal thickness were recorded systematically at the start of the treatment ...

M. V. Amarnath

Chinmaya Mission Hospital, Bangalore, Karnataka, India.

DOI: 10.13040/IJPSR.0975-8232.IJP.6(12).407-10

407-410

983

363